Acute generalized exanthematous pustulosis following oral nystatin therapy: a report of three cases.
We report three cases of acute generalized exanthematous pustulosis (AGEP) following oral administration of nystatin. All cases showed similar clinical features and histopathological findings, and a delayed-type hypersensitivity to nystatin could be demonstrated in patch and prick testing. Drug eruptions to nystatin are extremely rare, and, to our knowledge. AGEP has not been reported previously.
Küchler
A
A
Department of Dermatology, University Hospital, University of Würzburg.
Hamm
H
H
Weidenthaler-Barth
B
B
Kämpgen
E
E
Bröcker
E B
EB
D000208:Acute Disease; D000328:Adult; D000935:Antifungal Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D005076:Exanthema / Q000139:chemically induced* / Q000473:pathology; D005260:Female; D006801:Humans; D008875:Middle Aged; D009761:Nystatin / Q000009:adverse effects*
D000935:Antifungal Agents; D009761:Nystatin